Filtravate

About

Filtravate is a cutting-edge membrane technology company located in Las Cruces, New Mexico, specializing in advanced ultrafiltration membranes for the pharmaceutical and bioprocessing industries. As an NSF-funded company and member of the VIC Technology Venture Development portfolio, Filtravate develops proprietary membrane solutions engineered from the ground up using precise molecular building blocks. The company leverages patent-pending technology licensed from New Mexico State University to create membranes with controlled and tunable pore sizes, even pore distribution, and functionalized surfaces. These innovative characteristics deliver significant anti-fouling properties and improved flux performance, making them ideal for demanding biopharmaceutical applications. Filtravate focuses on bioprocessing manufacturing needs, providing membrane filtration solutions that enhance efficiency and reliability in pharmaceutical production processes. Their technology addresses critical challenges in the industry by offering superior membrane performance and longevity compared to conventional filtration systems. With their motto "Filter the Future," Filtravate combines academic research excellence with commercial manufacturing expertise to deliver next-generation membrane technologies. The company serves pharmaceutical manufacturers, biotechnology firms, and research institutions requiring high-performance ultrafiltration solutions for their critical processes and applications.